Replies to post #836 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

My expectations with respect to Viekirax/Exviera EU pricing were already pretty low: an average selling price of $25K (#msg-94993406); hence, I don’t think an adjustment is needed to take account of the somewhat stronger US dollar relative to the Euro compared to one year ago.